Finance Home
-
My Yahoo
-
Yahoo!
-
Help
Monday, November 30, 2009, 7:04PM ET - U.S. Markets Closed.
Dow
0.34%
Nasdaq
0.29%
Home
Investing
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
New!
Education
News & Opinion
Markets
Investing Ideas
Expert Advice
Special Editions
Company Finances
Providers
Personal Finance
Banking & Budgeting
Career & Work
College & Education
Family & Home
Insurance
Loans
Real Estate
Retirement
Taxes
How-to Guides
My Portfolios
Sign In to Create/Edit My Portfolios
Free trial of Real-Time Quotes
Tech Ticker
Get Quotes
Finance Search
AMAG Pharmaceuticals, Inc. (AMAG)
At
4:00PM ET
:
37.39
0.41
(1.08%)
MORE ON AMAG
Quotes
Summary
Real-Time
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Financial Blogs
Company Events
Message Board
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Research Reports
Get
Research Reports
for:
RECENT REPORTS
Released
Contributor
Author
Title
Pages
Price
30-Nov-2009
Plunkett Research, Ltd.
Jack W. Plunkett
Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary)
34
$199
30-Nov-2009
Plunkett Research, Ltd.
Jack W. Plunkett
Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009
447
$299
30-Nov-2009
Pechala's Reports
Lubomir Pechala
AMAG PHARMACEUTICALS INC (AMAG=US) - REPORT FOR ACTIVE TRADERS
4
$25
30-Nov-2009
ValuEngine, Inc.
N/A
ValuEngine Detailed Valuation Report for AMAG
13
$25
29-Nov-2009
ValuEngine, Inc.
N/A
ValuEngine Industry Report for MEDICAL SUPPLIES
18
$49
29-Nov-2009
PriceTarget Research, Inc.
N/A
Amag Pharmaceuticals has a current Overall Rating of F (Lowest Rating).
7
$25
29-Nov-2009
Wright Reports
N/A
Wright Investors Service Comprehensive Report for Amag Pharmaceuticals Incorporation
41
$65
28-Nov-2009
PriceTarget Research, Inc.
N/A
Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards.
65
$20
28-Nov-2009
Standard & Poor's Quantitative Report
N/A
AMAG Pharmaceuticals
6
$25
27-Nov-2009
Pechala's Reports
Frantisek Pechala
ADVANCED MAGNETICS INC (AMAG=US) 12-months forecast
1
$15
View All Reports for AMAG ...
Add to Portfolio
Set Alert
Email to a Friend
Get
Research Reports
for Another Symbol:
Symbol Lookup
Upgrades & Downgrades
Conference Calls